Bullish & Foolish
Full MODD fundamentals All 466 on the Survival Watch

MODDMODULAR MEDICAL, INC.

Is Modular Medical struggling financially?

Yes, by its own account. Modular Medical told the SEC on 29 Jun 2026, in Form 10-K, that there is substantial doubt about its ability to continue as a going concern.

Going concern disclosed Jun 2026

15/100

Critical

Cries for help

  • Needs to raise money

    Even with these proceeds, we do not believe that our cash and cash equivalents will be sufficient to fund our operations for the next 12 months, and we will need to raise additional capital.

    Form 10-K, filed 29 Jun 2026. Read it on SEC.gov

  • Reverse stock split

    Our board of directors is able to adopt recapitalizations through forward or reverse splits of our outstanding shares of common stock without stockholder approval.

    Form 10-K, filed 29 Jun 2026. Read it on SEC.gov

Signs of a way out

Nothing in the filings we have read names a way out.

Sector
Biotech/Pharma
Market cap
$28.9M
Source filing
10-K 29 Jun 2026
Balance sheet
30 Jun 2026

Cash runway

  • 1month

    If the burn speeds up

    Empty by Jul 2026

  • 2months

    If it eases off

    Empty by Aug 2026

Both rows are the same reported burn flexed 15% either way, and neither assumes the company raises a cent.

Out of cashTwo years or more

The runway math

Cash and short-term investments

$3.9M

÷

Cash burned over the last 12 months

$27.7M

What Modular Medical told the SEC

…or equity arrangements, there will be uncertainty regarding our ability to maintain liquidity sufficient to operate our business effectively, which raises substantial doubt as to our ability to continue as a going concern. If we cannot continue as a viable entity, our shareholders would likely lose most or all of their investment in us. If we are unable to generate sustainable operating profit and…

MODULAR MEDICAL, INC., Form 10-K, filed 29 Jun 2026.

Read the filing on SEC.gov

What this means

  • Not a bankruptcy filing, and not a prediction.
  • It is the company’s own statement, agreed with its auditor, that the doubt is material enough to disclose.
  • The runway is arithmetic on two reported numbers, not a forecast. Companies carry this language for years, raise money and keep going.

Other Biotech/Pharma companies that filed the doubt